ArticleNPJ vaccines2025
Pro-inflammatory cytokine profiles and neutralizing antibodies in JYNNEOS-vaccinated and mpox-diagnosed individuals.
Article in NPJ vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Monkey pox (Mpox): pathogenesis, genetic shifts, vaccination strategies and clinical insights.Archives of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Mpox is a significant health concern as an infectious disease. Therefore, understanding the immune response triggered in individuals vaccinated with JYNNEOS and those diagnosed with mpox requires further investigation. In this study, we evaluated neutralizing antibody (nAb) titers and profiles of pro-inflammatory and anti-inflammatory cytokines in JYNNEOS-vaccinated individuals with and without prior exposure to poxvirus, as well as in those who were unvaccinated and diagnosed with mpox. Samples were collected from 23 individuals at multiple time points, before vaccination (D0) and after vaccination (D7, D14, D30, D60, and D150), along with 8 samples from individuals with mpox. We observed a significant increase in nAb titers in naive-vaccinated individuals at D60, followed by a long-term decline at D150. The nAb response was significantly higher in the mpox-diagnosed group compared to the naive-vaccinated group at several time points. However, pre-exposed-vaccinated individuals showed significantly higher nAb titers than those with mpox on D14 and D60. A significant increase in the levels of cytokines IL-6 and IL-8 was detected at D30 in naive-vaccinated individuals. These findings enhance our understanding of the immunogenicity and protective mechanisms induced by JYNNEOS vaccination and highlight a previously unreported pro-inflammatory response as part of the immune repertoire triggered post-vaccination.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.